Status:
COMPLETED
Plasticity of the Compassionate Brain
Lead Sponsor:
Max Planck Institute for Human Cognitive and Brain Sciences
Collaborating Sponsors:
European Research Council
Conditions:
Healthy Subjects
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
The purpose of the study is to look at the long term effects of a complex socio-affective mental training program on a neuroscientific-, hormonal-, behavioral-, biological, and subjective measures-lev...
Detailed Description
The ReSource Project is a unique, large-scale study on the effects of mental training techniques. Over a period of three to nine months, participants practice a wide range of mental exercises that are...
Eligibility Criteria
Inclusion
- is a healthy, normal subject
Exclusion
- can not participate in the kick-off retreats
- does not have a PC with internet connection at home
- does not speak and understand German fluently
- has studied or is studying Psychology/Psychotherapy
- has a daily meditation practice
- attended a meditation retreat within the last 2 years
- exceeds normal BDI
- not able to lie still in MRT scanner for scanning duration
- is pregnant or in lactation or plans to become pregnant
- has had a larger surgery or plans to have one during the next year
- has metal parts in the body (due to MRT scanning)
- has a cardiac pacemaker
- carries an insulin or medicine pump
- carries a shunt
- has a heart valve
- has an inner ear implant
- carries metal, piercings or electronics on / in the body, that cannot be removed
- has a tattoo in the head / throat area
- works in the field of metal processing (if that leads to small metal parts on the body, that cannot be removed)
- has dyslexia or ametropia
- has claustrophobia (MRI scanner)
- has severe hearing problems (MRI scanner)
- has limitations with motor functions
- has or had a severe injury in the head area
- has or had a neurological disease (meningitis, cerebral hemorrhage, cerebral infarct, brain trauma, coma etc.)
- has or had epilepsy
- has a severe disease targeting the musculoskeletal system
- has a heart disease
- has a (peripheral) vascular disease, circulatory disorder, Raynaud´s disease
- has a liver disease
- has a respiratory disease
- has an affected kidney
- has an advanced multiple sclerosis
- has an infection (e.g., HIV)
- is in treatment due to chronic pain
- is on medication that effects the central nervous system (psychotropic drugs) during the last three months
- has been diagnosed with a mental health disease and is in treatment at the moment or within the last 2 years
- reaches clinical scores in the following questionnaires: TAS-20, MDI, STAI-trait, PHQ;
- reaches clinical scores following DSM-IV as determined by a SCID I and SCID II clinical interview
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT01833104
Start Date
January 1 2013
End Date
February 1 2016
Last Update
December 14 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Max Planck Institute for Human Cognitive and Brain Sciences
Leipzig, Saxony, Germany, 04103
2
Max Planck Institute, Humboldt University, Campus Nord, Haus 5
Berlin, State of Berlin, Germany, 10099